Filter
455
Text search:
antimalarial
drugs
Featured
Recommendations
54
New Publications
154
Language
Document type
No document type
256
Studies & Reports
70
Guidelines
57
Manuals
24
Training Material
16
Strategic & Response Plan
14
Fact sheets
9
Resource Platforms
4
Infographics
3
Situation Updates
2
Countries / Regions
Uganda
26
Global
26
India
24
Kenya
22
Sierra Leone
19
Liberia
18
Nigeria
17
Malawi
15
Zambia
14
Rwanda
14
Ghana
13
Tanzania
13
Ethiopia
12
Africa
11
Senegal
9
Latin America and the Carribbean
8
Nepal
6
Cambodia
6
Zimbabwe
5
Philippines
5
South Africa
5
Mozambique
5
South–East Asia Region
5
Cameroon
4
Thailand
4
Bangladesh
4
Vietnam
4
South Sudan
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
Asia
3
Laos
3
Burkina Faso
2
Somalia
2
Pakistan
2
China
2
Botswana
2
West and Central Africa
2
North America
2
Congo, Democratic Republic of
1
Mali
1
Lebanon
1
Chad
1
Indonesia
1
Namibia
1
Brazil
1
Libya
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Solomon Islands
1
Venezuela
1
Southern Africa
1
Timor Leste/ East Timor
1
Authors & Publishers
Publication Years
Category
Countries
255
Clinical Guidelines
46
Women & Child Health
29
Capacity Building
19
Public Health
19
Key Resources
13
Pharmacy & Technologies
12
Toolboxes
Malaria
76
Pharmacy
29
AMR
20
Ebola & Marburg
15
HIV
13
COVID-19
6
Caregiver
5
NTDs
5
Health Financing Toolbox
5
Rapid Response
4
2.0 Rapid Response
3
Polio
2
Conflict
2
Mental Health
2
Disability
1
Cholera
1
Natural Hazards
1
Zika
1
TB
1
Global Health Education
1
Planetary Health
1
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two
...
In November 2022, WHO launched a strategy to address antimalarial drug resistance in Africa, emphasizing the need for stronger surveillance. While regional monitoring networks have been active in other regions, most in Africa have not convened since
...
Presentation
New England Journal of Medicine 374:1,pp23-32
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o
...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this
...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic
...
Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T
The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy
...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
Prices people pay for medicines.
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn
...
DIAGNOSIS, MANAGEMENT OF UNCOMPLICATED AND SEVERE MALARIA
